Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Jun 9;58(9):2100–2108. doi: 10.2337/db09-0382

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2009 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

PMC Copyright notice

FIG. 2. — Average plasma glucagon (A), growth hormone (B), pancreatic polypeptide (C), and cortisol (D) levels (means ± SE) during the final 30 min of day 2 exercise in 22 type 1 diabetic patients (11 men/11 women). On the previous day, patients had undergone two 120-min euglycemic clamps (anteEugly), hypoglycemic clamps (anteHypo), or euglycemic clamps with intravenous cortisol infusions at 1 μg · kg⁻¹ · min⁻¹ (anteCort1) or 2 μg · kg⁻¹ · min⁻¹ (anteCort2) on day 1. There were significantly fewer increments of glucagon, growth hormone, and pancreatic polypeptide during the final 30 min of exercise from basal levels in anteHypo and anteCort compared with anteEugly. *P < 0.05.